In an immunohistochemistry based screening study, Chalitta-Eid et al. found positivity of Nectin-4 in bladder cancer (83%), and other solid cancers including HNSCC, which was positive in 59% of cases [6]. This evidence concerns the gene NECTIN4 and head and neck squamous cell carcinoma.